home / stock / phio / phio quote
Last: | $5.2447 |
---|---|
Change Percent: | 803.01% |
Open: | $5 |
Close: | $0.5808 |
High: | $5.45 |
Low: | $4.71 |
Volume: | 29,548 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.2447 | $5 | $0.5808 | $5.45 | $4.71 | 29,548 | 07-05-2024 |
$0.5808 | $0.58 | $0.5808 | $0.6027 | $0.57 | 133,033 | 07-04-2024 |
$0.5808 | $0.58 | $0.5808 | $0.6027 | $0.57 | 133,033 | 07-03-2024 |
$0.6101 | $0.7052 | $0.6101 | $0.72 | $0.58 | 233,378 | 07-02-2024 |
$0.6717 | $0.662 | $0.6717 | $0.697 | $0.662 | 21,963 | 07-01-2024 |
$0.6919 | $0.6601 | $0.6919 | $0.7201 | $0.6601 | 22,446 | 06-28-2024 |
$0.689199 | $0.7001 | $0.689199 | $0.7001 | $0.651 | 72,972 | 06-27-2024 |
$0.7002 | $0.6915 | $0.7002 | $0.72 | $0.69 | 18,202 | 06-26-2024 |
$0.7263 | $0.7246 | $0.7263 | $0.7263 | $0.69 | 10,678 | 06-25-2024 |
$0.71 | $0.68 | $0.71 | $0.7263 | $0.68 | 7,228 | 06-24-2024 |
$0.685 | $0.73 | $0.685 | $0.73 | $0.685 | 61,363 | 06-21-2024 |
$0.7129 | $0.7129 | $0.7129 | $0.74 | $0.69 | 51,112 | 06-20-2024 |
$0.7129 | $0.7426 | $0.7129 | $0.7588 | $0.69 | 311,403 | 06-19-2024 |
$0.7129 | $0.7426 | $0.7129 | $0.7588 | $0.69 | 311,403 | 06-18-2024 |
$0.732 | $0.7111 | $0.732 | $0.7321 | $0.7 | 19,616 | 06-17-2024 |
$0.7105 | $0.701101 | $0.7105 | $0.76 | $0.701101 | 10,394 | 06-14-2024 |
$0.73 | $0.7532 | $0.73 | $0.7532 | $0.681 | 12,955 | 06-13-2024 |
$0.718 | $0.78 | $0.718 | $0.78 | $0.68 | 55,613 | 06-12-2024 |
$0.75 | $0.7445 | $0.75 | $0.759 | $0.73 | 27,649 | 06-11-2024 |
$0.7575 | $0.7575 | $0.7575 | $0.7595 | $0.72 | 7,769 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
803.01%Change Percent:
Phio Pharmaceuticals Corp. Company Name:
PHIO Stock Symbol:
NASDAQ Market:
Phio Pharmaceuticals Corp. Website:
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced i...
2024-07-04 09:02:05 ET Phio Pharmaceuticals Corp (PHIO) announced stock split at a ratio of 1-for-9 on 2024-07-05 ... Full story available on KlickAnalytics.com
Phio's Compound RXI-185 is designed to slow progression of UV induced collagen breakdown Marlborough, Massachusetts--(Newsfile Corp. - June 18, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL ® siRNA gene silencing techno...